Energy Services of America (ESOA) completes $6.95m FAMCO acquisition to expand water infrastructure business
Read More Pharma Industry News Heron Therapeutics (Nasdaq: HRTX) withdraws 2026 guidance as CINVANTI patent ruling reshapes plan Heron Therapeutics withdrew 2026 guidance and cut $13.5m of Hercules debt after a June Delaware ruling on CINVANTI, with monthly covenants now running through 2027. bySrinathAugust 10, 2026